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Background: Aldosterone elevation (escape) despite renin-angiotensin-aldosterone system (RAAS) antagonism is frequently observed in heart 
failure (HF) patients and holds prognostic value. Our aim was to identify determinants of aldosterone escape by investigation of either genomic or 
non-genomic variables, never conducted before.
Methods: We enrolled 133 consecutive patients with left ventricular (LV) systolic dysfunction (ejection fraction, EF, 33± 9%, 83% males; age 64±14 
years; m± SD) on optimized adrenergic and RAAS drug antagonism, undergoing clinical, neuroendocrine characterization, and genotyping for 6 
polymorphisms in key RAAS-regulating genes (angiotensinogen [AGT M235T], angiotensin converting enzyme [ACE -240A>T and I/D], angiotensin II 
type I receptor [AGTR1 1166A>C], aldosterone synthase [CYP11B2 -344C>T] and renin [REN rs7539596]).
Results: Aldosterone escape (i.e. plasma concentration >180 ng/L, URL), was observed in 38% of patients (median 300 ng/L, IQR 225-426 vs 104 
ng/L, 66-144; p<0.001), who presented with higher frequency of AGT 235T allele (38% vs 52%; p=0.030), similar EF (p=0.356), greater LV diameters 
(p=0.046), worse renal function (p=0.024), lower sodium and higher potassium level (p=0.012 and p=0.019, respectively), higher PRA (6.45 ng/
mL/h, 1.43-9.20 vs 0.96 ng/mL/h, 0.21-2.21; p<0.001) and norepinephrine level (683 ng/L, 454-992 vs 497 ng/L, 346-669; p=0.002), compared 
to patients without aldosterone escape. At Cox multivariate analysis, among several functional, biohumoral and therapeutical variables, only PRA 
(p=0.002) and AGT 235TT genotype (p=0.010) were independent predictors of aldosterone elevation.
Conclusions: Aldosterone escape in HF is determined by both AGT M235T polymorphism and PRA, which may represent, respectively, a constitutive 
(genotype dependent), and a non-genomic (phenotype dependent) trigger for aldosterone elevation.
